Clinical Trial Update: Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL [NA]

View source ↗

Summary

An ongoing clinical trial evaluating a tyrosine kinase inhibitor combined with chemotherapy and sequential CAR-T cell therapy in newly diagnosed adults with Phi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Philadelphia Positive Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Adult | NA | Status: RECRUITING